Jordan, M., Locatelli, F., Halimi, D., Burillo, E., Jamieson, B., Danquah, A., Monnet, E. (2025). Emapalumab induces rapid, durable responses and reliable bridging to curative HSCT in patients with primary HLH: Pooled analysis of prospective trials NI-0501-04, NI-0501-05 and NI-0501-09. Blood. https://doi.org/10.1182/blood-2025-4758